Now showing items 1-9 of 9

  • Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis. 

    Hobart, J; Cano, S; Baron, R; Thompson, A; Schwid, S; Zajicek, J; Andrich, D (England, 2013-11)
    BACKGROUND: The increasing influence of patient-reported outcome (PRO) measurement instruments indicates their scrutiny has never been more crucial. Above all, PRO instruments should be valid: shown to assess what they ...
  • Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies. 

    Carroll, C; Palmer, A; Cosby, C; Zajicek, J (England, 2012-06)
    Promotion of research is a key strategy of the National Health Service (NHS). Currently, many patients are not afforded the opportunity to participate in clinical studies. A register of research-interested patients has ...
  • CBD & D9-THC - the two faces of cannabis 

    Zeissler; Carroll, CB; Zajicek, J (2010-05-10)
    Cannabidiol (CBD) and D9-tetrahydrocannabinol (D9-THC) are phytocannabinoids produced by the plant Cannabis sativa which have both shown promising therapeutic value as anti-inflammatory and neuroprotective agents in a ...
  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. 

    International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2; Sawcer, S; Hellenthal, G; Pirinen, M; Spencer, CCA; Patsopoulos, NA; Moutsianas, L; Dilthey, A; Su, Z; Freeman, C; Hunt, SE; Edkins, S; Gray, E; Booth, DR; Potter, SC; Goris, A; Band, G; Oturai, AB; Strange, A; Saarela, J; Bellenguez, C; Fontaine, B; Gillman, M; Hemmer, B; Gwilliam, R; Zipp, F; Jayakumar, A; Martin, R; Leslie, S; Hawkins, S; Giannoulatou, E; D'alfonso, S; Blackburn, H; Martinelli Boneschi, F; Liddle, J; Harbo, HF; Perez, ML; Spurkland, A; Waller, MJ; Mycko, MP; Ricketts, M; Comabella, M; Hammond, N; Kockum, I; McCann, OT; Ban, M; Whittaker, P; Kemppinen, A; Weston, P; Hawkins, C; Widaa, S; Zajicek, J; Dronov, S; Robertson, N; Bumpstead, SJ; Barcellos, LF; Ravindrarajah, R; Abraham, R; Alfredsson, L; Ardlie, K; Aubin, C; Baker, A; Baker, K; Baranzini, SE; Bergamaschi, L; Bergamaschi, R; Bernstein, A; Berthele, A; Boggild, M; Bradfield, JP; Brassat, D; Broadley, SA; Buck, D; Butzkueven, H; Capra, R; Carroll, WM; Cavalla, P; Celius, EG; Cepok, S; Chiavacci, R; Clerget-Darpoux, F; Clysters, K; Comi, G; Cossburn, M; Cournu-Rebeix, I; Cox, MB; Cozen, W; Cree, BAC; Cross, AH; Cusi, D; Daly, MJ; Davis, E; de Bakker, PIW; Debouverie, M; D'hooghe, MB; Dixon, K; Dobosi, R; Dubois, B; Ellinghaus, D; Elovaara, I; Esposito, F; Fontenille, C; Foote, S; Franke, A; Galimberti, D; Ghezzi, A; Glessner, J; Gomez, R; Gout, O; Graham, C; Grant, SFA; Guerini, FR; Hakonarson, H; Hall, P; Hamsten, A; Hartung, H-P; Heard, RN; Heath, S; Hobart, J; Hoshi, M; Infante-Duarte, C; Ingram, G; Ingram, W; Islam, T; Jagodic, M; Kabesch, M; Kermode, AG; Kilpatrick, TJ; Kim, C; Klopp, N; Koivisto, K; Larsson, M; Lathrop, M; Lechner-Scott, JS; Leone, MA; Leppä, V; Liljedahl, U; Bomfim, IL; Lincoln, RR; Link, J; Liu, J; Lorentzen, AR; Lupoli, S; Macciardi, F; Mack, T; Marriott, M; Martinelli, V; Mason, D; McCauley, JL; Mentch, F; Mero, I-L; Mihalova, T; Montalban, X; Mottershead, J; Myhr, K-M; Naldi, P; Ollier, W; Page, A; Palotie, A; Pelletier, J; Piccio, L; Pickersgill, T; Piehl, F; Pobywajlo, S; Quach, HL; Ramsay, PP; Reunanen, M; Reynolds, R; Rioux, JD; Rodegher, M; Roesner, S; Rubio, JP; Rückert, I-M; Salvetti, M; Salvi, E; Santaniello, A; Schaefer, CA; Schreiber, S; Schulze, C; Scott, RJ; Sellebjerg, F; Selmaj, KW; Sexton, D; Shen, L; Simms-Acuna, B; Skidmore, S; Sleiman, PMA; Smestad, C; Sørensen, PS; Søndergaard, HB; Stankovich, J; Strange, RC; Sulonen, A-M; Sundqvist, E; Syvänen, A-C; Taddeo, F; Taylor, B; Blackwell, JM; Tienari, P; Bramon, E; Tourbah, A; Brown, MA; Tronczynska, E; Casas, JP; Tubridy, N; Corvin, A; Vickery, J; Jankowski, J; Villoslada, P; Markus, HS; Wang, K; Mathew, CG; Wason, J; Palmer, CNA; Wichmann, H-E; Plomin, R; Willoughby, E; Rautanen, A; Winkelmann, J; Wittig, M; Trembath, RC; Yaouanq, J; Viswanathan, AC; Zhang, H; Wood, NW; Zuvich, R; Deloukas, P; Langford, C; Duncanson, A; Oksenberg, JR; Pericak-Vance, MA; Haines, JL; Olsson, T; Hillert, J; Ivinson, AJ; De Jager, PL; Peltonen, L; Stewart, GJ; Hafler, DA; Hauser, SL; McVean, G; Donnelly, P; Compston, A (England, 2011-08-10)
    Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by ...
  • Machine-learning based identification of undiagnosed dementia in primary care: a feasibility study 

    Jammeh, EA; Carroll, CB; Pearson, SW; Escudero, J; Anastasiou, A; Zhao, P; Chenore, T; Zajicek, J; Ifeachor, E
  • Molecular genetic studies of neurodegenerative disease. 

    Cooke, T; Carroll, C; Zajicek, J; Ellard, S; Morrison, K (England, 2013-11)
    Large scale genetic studies such as genome-wide association studies (GWAS) in Parkinson's disease (PD) have revealed genetic susceptibility factors and continue to offer new insights both into the genetics of sporadic ...
  • Provision of 24 hour acute neurology care by neurologists: manpower requirements in the UK. 

    Carroll, C; Zajicek, J (England, 2004-03)
    OBJECTIVES: The ABN has published standards of care for patients with acute neurological disease. Derriford Hospital provides a 24 hour neurology intake service to a population of 500,000 with the equivalent of four ...
  • Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks. 

    Liu, X; Carroll, CB; Wang, S-Y; Zajicek, J; Bain, PG (Netherlands, 2005-05-15)
    In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's disease (PD) patients using digitised spiral-drawing tasks. Two spiral drawings, namely a circular and a square spiral, are ...

    Zeissler, ML; Eastwood, J; Oliver Hanemann, C; Zajicek, J; Carroll, C (England, 2013-11)
    Cannabinoids such as Δ9-tetrahydrocannabinol (Δ9-THC) are neuroprotective in animal and cell culture models of Parkinson's disease (PD). In a PD cell culture model we recently demonstrated that Δ9-THC is neuroprotective ...

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
@mire NV